{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:53:56Z","timestamp":1786737236556,"version":"build-2736575974"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/1673-5374.301031","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T12:27:17Z","timestamp":1608208037000},"page":"1244","source":"Crossref","is-referenced-by-count":25,"title":["Delayed atomoxetine or fluoxetine treatment coupled with limited voluntary running promotes motor recovery in mice after ischemic stroke"],"prefix":"10.4103","volume":"16","author":[{"given":"VardanT","family":"Karamyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FaisalF","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al Shoyaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Syeara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinidhi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SerobT","family":"Karamyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ThirumaV","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.301031-1","doi-asserted-by":"crossref","unstructured":"Al Shoyaib A, Archie SR, Karamyan VT (2019) Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm Res 37:12.","DOI":"10.1007\/s11095-019-2745-x"},{"key":"key-10.4103\/1673-5374.301031-2","doi-asserted-by":"crossref","unstructured":"Alamri FF, Shoyaib AA, Biggers A, Jayaraman S, Guindon J, Karamyan VT (2018) Applicability of the grip strength and automated von Frey tactile sensitivity tests in the mouse photothrombotic model of stroke. Behav Brain Res 336:250-255.","DOI":"10.1016\/j.bbr.2017.09.008"},{"key":"key-10.4103\/1673-5374.301031-3","doi-asserted-by":"crossref","unstructured":"Asadollahi M, Ramezani M, Khanmoradi Z, Karimialavijeh E (2018) The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial. Clin Rehabil 32:1069-1075.","DOI":"10.1177\/0269215518777791"},{"key":"key-10.4103\/1673-5374.301031-4","doi-asserted-by":"crossref","unstructured":"Bernhardt J, Godecke E, Johnson L, Langhorne P (2017a) Early rehabilitation after stroke. Curr Opin Neurol 30:48-54.","DOI":"10.1097\/WCO.0000000000000404"},{"key":"key-10.4103\/1673-5374.301031-5","doi-asserted-by":"crossref","unstructured":"Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann K, Krakauer JW, Boyd LA, Carmichael ST, Corbett D, Cramer SC (2017b) Agreed definitions and a shared vision for new standards in stroke recovery research: The Stroke Recovery and Rehabilitation Roundtable taskforce. Int J Stroke 12:444-450.","DOI":"10.1177\/1747493017711816"},{"key":"key-10.4103\/1673-5374.301031-6","doi-asserted-by":"crossref","unstructured":"Bernhardt J, Borschmann K, Boyd L, Thomas Carmichael S, Corbett D, Cramer SC, Hoffmann T, Kwakkel G, Savitz SI, Saposnik G, Walker M, Ward N (2016) Moving rehabilitation research forward: Developing consensus statements for rehabilitation and recovery research. Int J Stroke 11:454-458.","DOI":"10.1177\/1747493016643851"},{"key":"key-10.4103\/1673-5374.301031-7","doi-asserted-by":"crossref","unstructured":"Bernhardt J, Hayward KS, Dancause N, Lannin NA, Ward NS, Nudo RJ, Farrin A, Churilov L, Boyd LA, Jones TA, Carmichael ST, Corbett D, Cramer SC (2019) A stroke recovery trial development framework: Consensus-based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable. Int J Stroke 14:792-802.","DOI":"10.1177\/1747493019879657"},{"key":"key-10.4103\/1673-5374.301031-8","doi-asserted-by":"crossref","unstructured":"Birjandi SZ, Abduljawad N, Nair S, Dehghani M, Suzuki K, Kimura H, Carmichael ST (2020) Phosphodiesterase 10A inhibition leads to brain region-specific recovery based on stroke type. Transl Stroke Res doi: 10.1007\/s12975-020-00819-8.","DOI":"10.1007\/s12975-020-00819-8"},{"key":"key-10.4103\/1673-5374.301031-9","doi-asserted-by":"crossref","unstructured":"Borodovitsyna O, Flamini M, Chandler D (2017) Noradrenergic modulation of cognition in health and disease. Neural Plast 2017:6031478.","DOI":"10.1155\/2017\/6031478"},{"key":"key-10.4103\/1673-5374.301031-10","doi-asserted-by":"crossref","unstructured":"Carmichael ST (2016) Emergent properties of neural repair: elemental biology to therapeutic concepts. Ann Neurol 79:895-906.","DOI":"10.1002\/ana.24653"},{"key":"key-10.4103\/1673-5374.301031-11","doi-asserted-by":"crossref","unstructured":"Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10:123-130.","DOI":"10.1016\/S1474-4422(10)70314-8"},{"key":"key-10.4103\/1673-5374.301031-12","doi-asserted-by":"crossref","unstructured":"Christie BR, Eadie BD, Kannangara TS, Robillard JM, Shin J, Titterness AK (2008) Exercising our brains: how physical activity impacts synaptic plasticity in the dentate gyrus. Neuromolecular Med 10:47-58.","DOI":"10.1007\/s12017-008-8033-2"},{"key":"key-10.4103\/1673-5374.301031-13","doi-asserted-by":"crossref","unstructured":"Christman AK, Fermo JD, Markowitz JS (2004) Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy 24:1020-1036.","DOI":"10.1592\/phco.24.11.1020.36146"},{"key":"key-10.4103\/1673-5374.301031-14","doi-asserted-by":"crossref","unstructured":"Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST (2010) Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468:305-309.","DOI":"10.1038\/nature09511"},{"key":"key-10.4103\/1673-5374.301031-15","unstructured":"Collaboration AT (2020a) Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 19:651-660."},{"key":"key-10.4103\/1673-5374.301031-16","doi-asserted-by":"crossref","unstructured":"Collaboration ET (2020b) Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 19:661-669.","DOI":"10.1016\/S1474-4422(20)30219-2"},{"key":"key-10.4103\/1673-5374.301031-17","doi-asserted-by":"crossref","unstructured":"Collaboration FT (2019) Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 393:265-274.","DOI":"10.1016\/S0140-6736(18)32823-X"},{"key":"key-10.4103\/1673-5374.301031-18","doi-asserted-by":"crossref","unstructured":"Corbett D, Carmichael ST, Murphy TH, Jones TA, Schwab ME, Jolkkonen J, Clarkson AN, Dancause N, Weiloch T, Johansen-Berg H, Nilsson M, McCullough LD, Joy MT (2017) Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable translational working group. Int J Stroke 12:462-471.","DOI":"10.1177\/1747493017711814"},{"key":"key-10.4103\/1673-5374.301031-19","doi-asserted-by":"crossref","unstructured":"Cramer SC (2015) Drugs to enhance motor recovery after stroke. Stroke 46:2998-3005.","DOI":"10.1161\/STROKEAHA.115.007433"},{"key":"key-10.4103\/1673-5374.301031-20","doi-asserted-by":"crossref","unstructured":"Egan KJ, Janssen H, Sena ES, Longley L, Speare S, Howells DW, Spratt NJ, Macleod MR, Mead GE, Bernhardt J (2014) Exercise reduces infarct volume and facilitates neurobehavioral recovery: results from a systematic review and meta-analysis of exercise in experimental models of focal ischemia. Neurorehabil Neural Repair 28:800-812.","DOI":"10.1177\/1545968314521694"},{"key":"key-10.4103\/1673-5374.301031-21","doi-asserted-by":"crossref","unstructured":"Fini NA, Holland AE, Keating J, Simek J, Bernhardt J (2017) How physically active are people following stroke? Systematic review and quantitative synthesis. Phys Ther 97:707-717.","DOI":"10.1093\/ptj\/pzx038"},{"key":"key-10.4103\/1673-5374.301031-22","doi-asserted-by":"crossref","unstructured":"Fumagalli F, Cattaneo A, Caffino L, Ibba M, Racagni G, Carboni E, Gennarelli M, Riva MA (2010) Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res 62:523-529.","DOI":"10.1016\/j.phrs.2010.07.009"},{"key":"key-10.4103\/1673-5374.301031-23","doi-asserted-by":"crossref","unstructured":"Garcia C, Chen MJ, Garza AA, Cotman CW, Russo-Neustadt A (2003) The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 119:721-732.","DOI":"10.1016\/S0306-4522(03)00192-1"},{"key":"key-10.4103\/1673-5374.301031-24","doi-asserted-by":"crossref","unstructured":"Guo Y, He Y, Tang B, Ma K, Cai Z, Zeng S, Zhang Y, Jiang X (2016) Effect of using fluoxetine at different time windows on neurological functional prognosis after ischemic stroke. Restor Neurol Neurosci 34:177-187.","DOI":"10.3233\/RNN-150535"},{"key":"key-10.4103\/1673-5374.301031-25","doi-asserted-by":"crossref","unstructured":"Hatakeyama M, Ninomiya I, Kanazawa M (2020) Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res 15:16-19.","DOI":"10.4103\/1673-5374.264442"},{"key":"key-10.4103\/1673-5374.301031-26","doi-asserted-by":"crossref","unstructured":"Hodes GE, Hill-Smith TE, Lucki I (2010) Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neurosci Lett 484:12-16.","DOI":"10.1016\/j.neulet.2010.07.084"},{"key":"key-10.4103\/1673-5374.301031-27","doi-asserted-by":"crossref","unstructured":"Hu Q, Liu L, Zhou L, Lu H, Wang J, Chen X, Wang Q (2020) Effect of fluoxetine on HIF-1alpha- Netrin\/VEGF cascade, angiogenesis and neuroprotection in a rat model of transient middle cerebral artery occlusion. Exp Neurol 329:113312.","DOI":"10.1016\/j.expneurol.2020.113312"},{"key":"key-10.4103\/1673-5374.301031-28","doi-asserted-by":"crossref","unstructured":"Jayaraman S, Al Shoyaib A, Kocot J, Villalba H, Alamri FF, Rashid M, Wangler NJ, Chowdhury EA, German N, Arumugam TV, Abbruscato TJ, Karamyan VT (2020) Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice. J Neurochem 153:120-137.","DOI":"10.1111\/jnc.14864"},{"key":"key-10.4103\/1673-5374.301031-29","doi-asserted-by":"crossref","unstructured":"Jhaveri DJ, Mackay EW, Hamlin AS, Marathe SV, Nandam LS, Vaidya VA, Bartlett PF (2010) Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J Neurosci 30:2795-2806.","DOI":"10.1523\/JNEUROSCI.3780-09.2010"},{"key":"key-10.4103\/1673-5374.301031-30","doi-asserted-by":"crossref","unstructured":"Karamyan VT (2021) The role of peptidase neurolysin in neuroprotection and neural repair after stroke. Neural Regen Res 16:21-25.","DOI":"10.4103\/1673-5374.284904"},{"key":"key-10.4103\/1673-5374.301031-31","doi-asserted-by":"crossref","unstructured":"Kinoshita S, Kakuda W, Yamada N, Momosaki R, Okuma R, Watanabe S, Abo M (2016) Therapeutic administration of atomoxetine combined with rTMS and occupational therapy for upper limb hemiparesis after stroke: a case series study of three patients. Acta Neurol Belg 116:31-37.","DOI":"10.1007\/s13760-015-0503-3"},{"key":"key-10.4103\/1673-5374.301031-32","doi-asserted-by":"crossref","unstructured":"Klenotich SJ, Seiglie MP, McMurray MS, Roitman JD, Le Grange D, Dugad P, Dulawa SC (2012) Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice. Neuropsychopharmacology 37:1620-1631.","DOI":"10.1038\/npp.2012.7"},{"key":"key-10.4103\/1673-5374.301031-33","doi-asserted-by":"crossref","unstructured":"Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 114:259-270.","DOI":"10.1111\/j.1471-4159.2010.06750.x"},{"key":"key-10.4103\/1673-5374.301031-34","doi-asserted-by":"crossref","unstructured":"Krakauer JW, Carmichael ST, Corbett D, Wittenberg GF (2012) Getting neurorehabilitation right: what can be learned from animal models? Neurorehabil Neural Repair 26:923-931.","DOI":"10.1177\/1545968312440745"},{"key":"key-10.4103\/1673-5374.301031-35","doi-asserted-by":"crossref","unstructured":"Kraus C, Castren E, Kasper S, Lanzenberger R (2017) Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression. Neurosci Biobehav Rev 77:317-326.","DOI":"10.1016\/j.neubiorev.2017.03.007"},{"key":"key-10.4103\/1673-5374.301031-36","doi-asserted-by":"crossref","unstructured":"Kwakkel G, Meskers C, Ward NS (2020) Time for the next stage of stroke recovery trials. Lancet Neurol 19:636-637.","DOI":"10.1016\/S1474-4422(20)30218-0"},{"key":"key-10.4103\/1673-5374.301031-37","doi-asserted-by":"crossref","unstructured":"Lay S, Bernhardt J, West T, Churilov L, Dart A, Hayes K, Cumming TB (2016) Is early rehabilitation a myth? Physical inactivity in the first week after myocardial infarction and stroke. Disabil Rehabil 38:1493-1499.","DOI":"10.3109\/09638288.2015.1106598"},{"key":"key-10.4103\/1673-5374.301031-38","doi-asserted-by":"crossref","unstructured":"Ledbetter M (2006) Atomoxetine: a novel treatment for child and adult ADHD. Neuropsychiatr Dis Treat 2:455-466.","DOI":"10.2147\/nedt.2006.2.4.455"},{"key":"key-10.4103\/1673-5374.301031-39","doi-asserted-by":"crossref","unstructured":"Lenz M, Vlachos A, Maggio N (2015) Ischemic long-term-potentiation (iLTP): perspectives to set the threshold of neural plasticity toward therapy. Neural Regen Res 10:1537-1539.","DOI":"10.4103\/1673-5374.165215"},{"key":"key-10.4103\/1673-5374.301031-40","doi-asserted-by":"crossref","unstructured":"Lesch KP, Waider J (2012) Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76:175-191.","DOI":"10.1016\/j.neuron.2012.09.013"},{"key":"key-10.4103\/1673-5374.301031-41","doi-asserted-by":"crossref","unstructured":"Levy MJF, Boulle F, Emerit MB, Poilbout C, Steinbusch HWM, Van den Hove DLA, Kenis G, Lanfumey L (2019) 5-HTT independent effects of fluoxetine on neuroplasticity. Sci Rep 9:6311.","DOI":"10.1038\/s41598-019-42775-w"},{"key":"key-10.4103\/1673-5374.301031-42","doi-asserted-by":"crossref","unstructured":"Li WL, Cai HH, Wang B, Chen L, Zhou QG, Luo CX, Liu N, Ding XS, Zhu DY (2009) Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 87:112-122.","DOI":"10.1002\/jnr.21829"},{"key":"key-10.4103\/1673-5374.301031-43","doi-asserted-by":"crossref","unstructured":"Liu PZ, Nusslock R (2018) Exercise and hippocampal neurogenesis: a dogma re-examined and lessons learned. Neural Regen Res 13:1354-1355.","DOI":"10.4103\/1673-5374.235225"},{"key":"key-10.4103\/1673-5374.301031-44","doi-asserted-by":"crossref","unstructured":"Liu Y, Ishida Y, Shinoda K, Nakamura S (2003) Interaction between serotonergic and noradrenergic axons during axonal regeneration. Exp Neurol 184:169-178.","DOI":"10.1016\/S0014-4886(03)00221-8"},{"key":"key-10.4103\/1673-5374.301031-45","doi-asserted-by":"crossref","unstructured":"Lopez-Munoz F, Alamo C (2009) Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des 15:1563-1586.","DOI":"10.2174\/138161209788168001"},{"key":"key-10.4103\/1673-5374.301031-46","doi-asserted-by":"crossref","unstructured":"Marzo A, Bai J, Otani S (2009) Neuroplasticity regulation by noradrenaline in mammalian brain. Curr Neuropharmacol 7:286-295.","DOI":"10.2174\/157015909790031193"},{"key":"key-10.4103\/1673-5374.301031-47","doi-asserted-by":"crossref","unstructured":"Moon SJ, Kim CJ, Lee YJ, Hong M, Han J, Bahn GH (2014) Effect of atomoxetine on hyperactivity in an animal model of attention-deficit\/hyperactivity disorder (ADHD). PLoS One 9:e108918.","DOI":"10.1371\/journal.pone.0108918"},{"key":"key-10.4103\/1673-5374.301031-48","doi-asserted-by":"crossref","unstructured":"Murphy TH, Corbett D (2009) Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 10:861-872.","DOI":"10.1038\/nrn2735"},{"key":"key-10.4103\/1673-5374.301031-49","doi-asserted-by":"crossref","unstructured":"Ng KL, Gibson EM, Hubbard R, Yang J, Caffo B, O\u2019Brien RJ, Krakauer JW, Zeiler SR (2015) Fluoxetine maintains a state of heightened responsiveness to motor training early after stroke in a mouse model. Stroke 46:2951-2960.","DOI":"10.1161\/STROKEAHA.115.010471"},{"key":"key-10.4103\/1673-5374.301031-50","doi-asserted-by":"crossref","unstructured":"Nicholson S, Sniehotta FF, van Wijck F, Greig CA, Johnston M, McMurdo ME, Dennis M, Mead GE (2013) A systematic review of perceived barriers and motivators to physical activity after stroke. Int J Stroke 8:357-364.","DOI":"10.1111\/j.1747-4949.2012.00880.x"},{"key":"key-10.4103\/1673-5374.301031-51","doi-asserted-by":"crossref","unstructured":"Pina R, Rozas C, Contreras D, Hardy P, Ugarte G, Zeise ML, Rojas P, Morales B (2020) Atomoxetine reestablishes long term potentiation in a mouse model of attention deficit\/hyperactivity disorder. Neuroscience 439:268-274.","DOI":"10.1016\/j.neuroscience.2019.10.040"},{"key":"key-10.4103\/1673-5374.301031-52","doi-asserted-by":"crossref","unstructured":"Rashid M, Wangler NJ, Yang L, Shah K, Arumugam TV, Abbruscato TJ, Karamyan VT (2014) Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain. J Neurochem 129:179-189.","DOI":"10.1111\/jnc.12513"},{"key":"key-10.4103\/1673-5374.301031-53","doi-asserted-by":"crossref","unstructured":"Rossi A, Barraco A, Donda P (2004) Fluoxetine: a review on evidence based medicine. Ann Gen Hosp Psychiatry 3:2.","DOI":"10.1186\/1475-2832-3-2"},{"key":"key-10.4103\/1673-5374.301031-54","doi-asserted-by":"crossref","unstructured":"Rossi FM (2016) Analysis of fluoxetine-induced plasticity mechanisms as a strategy for understanding plasticity related neural disorders. Neural Regen Res 11:547-548.","DOI":"10.4103\/1673-5374.180731"},{"key":"key-10.4103\/1673-5374.301031-55","doi-asserted-by":"crossref","unstructured":"Sobrido-Camean D, Rodicio MC, Barreiro-Iglesias A (2018) Serotonin controls axon and neuronal regeneration in the nervous system: lessons from regenerating animal models. Neural Regen Res 13:237-238.","DOI":"10.4103\/1673-5374.226387"},{"key":"key-10.4103\/1673-5374.301031-56","doi-asserted-by":"crossref","unstructured":"Song T, Wu H, Li R, Xu H, Rao X, Gao L, Zou Y, Lei H (2019) Repeated fluoxetine treatment induces long-lasting neurotrophic changes in the medial prefrontal cortex of adult rats. Behav Brain Res 365:114-124.","DOI":"10.1016\/j.bbr.2019.03.009"},{"key":"key-10.4103\/1673-5374.301031-57","doi-asserted-by":"crossref","unstructured":"Stanton PK, Sarvey JM (1985) Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices. J Neurosci 5:2169-2176.","DOI":"10.1523\/JNEUROSCI.05-08-02169.1985"},{"key":"key-10.4103\/1673-5374.301031-58","doi-asserted-by":"crossref","unstructured":"Steinzeig A, Cannarozzo C, Castren E (2019) Fluoxetine-induced plasticity in the visual cortex outlasts the duration of the naturally occurring critical period. Eur J Neurosci 50:3663-3673.","DOI":"10.1111\/ejn.14512"},{"key":"key-10.4103\/1673-5374.301031-59","doi-asserted-by":"crossref","unstructured":"Sun X, Zhou Z, Liu T, Zhao M, Zhao S, Xiao T, Jolkkonen J, Zhao C (2016) Fluoxetine enhances neurogenesis in aged rats with cortical infarcts, but this is not reflected in a behavioral recovery. J Mol Neurosci 58:233-242.","DOI":"10.1007\/s12031-015-0662-y"},{"key":"key-10.4103\/1673-5374.301031-60","doi-asserted-by":"crossref","unstructured":"Syeara N, Alamri FF, Jayaraman S, Lee P, Karamyan ST, Arumugam TV, Karamyan VT (2019) Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke. Behav Brain Res 380:112418.","DOI":"10.1016\/j.bbr.2019.112418"},{"key":"key-10.4103\/1673-5374.301031-61","doi-asserted-by":"crossref","unstructured":"Trout AL, Kahle MP, Roberts JM, Marcelo A, de Hoog L, Boychuk JA, Grupke SL, Berretta A, Gowing EK, Boychuk CR, Gorman AA, Edwards DN, Rutkai I, Biose IJ, Ishibashi-Ueda H, Ihara M, Smith BN, Clarkson AN, Bix GJ (2020) Perlecan domain-V Enhances neurogenic brain repair after stroke in mice. Transl Stroke Res doi: 10.1007\/s12975-020-00800-5.","DOI":"10.1007\/s12975-020-00800-5"},{"key":"key-10.4103\/1673-5374.301031-62","doi-asserted-by":"crossref","unstructured":"Tsintou M, Dalamagkas K, Makris N (2020) Taking central nervous system regenerative therapies to the clinic: curing rodents versus nonhuman primates versus humans. Neural Regen Res 15:425-437.","DOI":"10.4103\/1673-5374.266048"},{"key":"key-10.4103\/1673-5374.301031-63","doi-asserted-by":"crossref","unstructured":"Tully K, Bolshakov VY (2010) Emotional enhancement of memory: how norepinephrine enables synaptic plasticity. Mol Brain 3:15.","DOI":"10.1186\/1756-6606-3-15"},{"key":"key-10.4103\/1673-5374.301031-64","doi-asserted-by":"crossref","unstructured":"Vahid-Ansari F, Albert PR (2018) Chronic fluoxetine induces activity changes in recovery from poststroke anxiety, depression, and cognitive impairment. Neurotherapeutics 15:200-215.","DOI":"10.1007\/s13311-017-0590-3"},{"key":"key-10.4103\/1673-5374.301031-65","doi-asserted-by":"crossref","unstructured":"van Praag H (2008) Neurogenesis and exercise: past and future directions. Neuromolecular Med 10:128-140.","DOI":"10.1007\/s12017-008-8028-z"},{"key":"key-10.4103\/1673-5374.301031-66","doi-asserted-by":"crossref","unstructured":"Wang CJ, Wu Y, Zhang Q, Yu KW, Wang YY (2019) An enriched environment promotes synaptic plasticity and cognitive recovery after permanent middle cerebral artery occlusion in mice. Neural Regen Res 14:462-469.","DOI":"10.4103\/1673-5374.245470"},{"key":"key-10.4103\/1673-5374.301031-67","doi-asserted-by":"crossref","unstructured":"Wangler NJ, Santos KL, Schadock I, Hagen FK, Escher E, Bader M, Speth RC, Karamyan VT (2012) Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (Non-AT1), Non-AT2 angiotensin binding site. J Biol Chem 287:114-122.","DOI":"10.1074\/jbc.M111.273052"},{"key":"key-10.4103\/1673-5374.301031-68","doi-asserted-by":"crossref","unstructured":"Ward A, Carrico C, Powell E, Westgate PM, Nichols L, Fleischer A, Sawaki L (2017) Safety and improvement of movement function after stroke with atomoxetine: A pilot randomized trial. Restor Neurol Neurosci 35:1-10.","DOI":"10.3233\/RNN-160673"},{"key":"key-10.4103\/1673-5374.301031-69","doi-asserted-by":"crossref","unstructured":"Windle V, Corbett D (2005) Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res 1044:25-32.","DOI":"10.1016\/j.brainres.2005.02.060"},{"key":"key-10.4103\/1673-5374.301031-70","unstructured":"Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research (2016) Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 47:e98-169."},{"key":"key-10.4103\/1673-5374.301031-71","doi-asserted-by":"crossref","unstructured":"Wong DT, Bymaster FP, Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57:411-441.","DOI":"10.1016\/0024-3205(95)00209-O"},{"key":"key-10.4103\/1673-5374.301031-72","doi-asserted-by":"crossref","unstructured":"Yamada N, Kakuda W, Yamamoto K, Momosaki R, Abo M (2016) Atomoxetine administration combined with intensive speech therapy for post-stroke aphasia: evaluation by a novel SPECT method. Int J Neurosci 126:829-838.","DOI":"10.3109\/00207454.2015.1074226"},{"key":"key-10.4103\/1673-5374.301031-73","doi-asserted-by":"crossref","unstructured":"Yang YW, Pan WX, Xie Q (2020) Combined effect of repetitive transcranial magnetic stimulation and physical exercise on cortical plasticity. Neural Regen Res 15:1986-1994.","DOI":"10.4103\/1673-5374.282239"},{"key":"key-10.4103\/1673-5374.301031-74","doi-asserted-by":"crossref","unstructured":"Zeiler SR, Gibson EM, Hoesch RE, Li MY, Worley PF, O\u2019Brien RJ, Krakauer JW (2013) Medial premotor cortex shows a reduction in inhibitory markers and mediates recovery in a mouse model of focal stroke. Stroke 44:483-489.","DOI":"10.1161\/STROKEAHA.112.676940"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:54Z","timestamp":1786733514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.301031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"alternative-id":["301031"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.301031","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}